These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20961308)

  • 21. Mesenteric lymphatic vessels adapt to mesenteric venous hypertension by becoming weaker pumps.
    Dongaonkar RM; Nguyen TL; Quick CM; Heaps CL; Hardy J; Laine GA; Wilson E; Stewart RH
    Am J Physiol Regul Integr Comp Physiol; 2015 Mar; 308(5):R391-9. PubMed ID: 25519727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactivation of inflammatory bowel disease in a mouse model of depression.
    Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
    Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease.
    Horowitz S; Binion DG; Nelson VM; Kanaa Y; Javadi P; Lazarova Z; Andrekopoulos C; Kalyanaraman B; Otterson MF; Rafiee P
    Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1323-36. PubMed ID: 17218473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?
    Reuter BK; Pizarro TT
    Eur J Immunol; 2004 Sep; 34(9):2347-55. PubMed ID: 15307167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease.
    Dieleman LA; Peña AS; Meuwissen SG; van Rees EP
    Scand J Gastroenterol Suppl; 1997; 223():99-104. PubMed ID: 9200314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal dysmotility in inflammatory bowel disease: mechanisms of the reduced activity of smooth muscle contraction.
    Ozaki H; Hori M; Kinoshita K; Ohama T
    Inflammopharmacology; 2005; 13(1-3):103-11. PubMed ID: 16259732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indomethacin-induced ileitis is associated with tensiometric, vascular and oxidative changes in the experimental rat model.
    Piepoli AL; De Salvatore G; De Salvia MA; Mitolo CI; Siro-Brigiani G; Marzullo A; Grattagliano I; Mitolo-Chieppa D; Palasciano G; Portincasa P
    Eur J Clin Invest; 2005 Apr; 35(4):271-8. PubMed ID: 15816997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
    Mielants H; Veys EM
    Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of innervation of human mesenteric vessels in non-inflamed and inflamed bowel--a confocal and functional study.
    Birch D; Knight GE; Boulos PB; Burnstock G
    Neurogastroenterol Motil; 2008 Jun; 20(6):660-70. PubMed ID: 18298440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.
    Chidlow JH; Shukla D; Grisham MB; Kevil CG
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G5-G18. PubMed ID: 17463183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation and colorectal cancer.
    Kraus S; Arber N
    Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of abnormal intestinal motility in inflammatory bowel disease: how smooth muscle contraction is reduced?
    Ohama T; Hori M; Ozaki H
    J Smooth Muscle Res; 2007 Apr; 43(2):43-54. PubMed ID: 17598957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of lymphatic alterations in the pathogenesis and treatment of inflammatory bowel disease.
    Zhang L; Ocansey DKW; Liu L; Olovo CV; Zhang X; Qian H; Xu W; Mao F
    Biomed Pharmacother; 2021 Aug; 140():111752. PubMed ID: 34044275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models of inflammatory bowel disease: lessons from enteric infections.
    Eckmann L
    Ann N Y Acad Sci; 2006 Aug; 1072():28-38. PubMed ID: 17057188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Joint involvement associated with inflammatory bowel disease.
    De Vos M
    Dig Dis; 2009; 27(4):511-5. PubMed ID: 19897967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
    Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
    J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
    Hatoum OA; Heidemann J; Binion DG
    Ann N Y Acad Sci; 2006 Aug; 1072():78-97. PubMed ID: 17057192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.